August 19, 2024Open Access

Genomic alterations in two patients with esophageal carcinosarcoma identified by whole genome sequencing: a case report

Key Points

Key points are not available for this paper at this time.

Abstract

Esophageal carcinosarcoma (ECS) is a relatively rare malignancy, accounting for < 1% of all esophageal cancers. Its etiopathogenesis remains unknown. This study analyzed the genomic abnormalities in sarcomatous tumors from two patients undergoing subtotal esophagectomy using whole genome sequencing to elucidate the key characteristics of ECS.

KI fragen

Bookmark

View Full Paper

Cite This Study

Inoue et al. (Mon,) studied this question.

synapsesocial.com/papers/68e5bc37b6db64358755430c https://doi.org/https://doi.org/10.1186/s40792-024-01978-8

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes2012 · 882 citations
2Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma2018 · 29 citations
3Molecular and clinicopathological analyses of esophageal carcinosarcoma with special reference to morphological change2019 · 9 citations
4H2AFY is a novel fusion partner of MECOM in acute myeloid leukemia2018 · 12 citations
5Germline mutations in a DNA repair pathway are associated with familial colorectal cancer2021 · 17 citations

KI fragen

Bookmark

View Full Paper